drugset / Trial / NCT03468543
Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects
Non-randomizedSequentialOpen-labelBasic science
Summary
To assess how long modified release (MR) memantine hydrochloride prototype capsule formulations stay in the stomach as determined by magnetic resonance imaging (MRI).
Timeline
- Start
- 2017-07-26
- Primary completion
- 2017-09-18
- Completion
- 2017-09-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Memantine | Unknown | 50 mg | Oral |